Liver Transplant Cholangiocarcinoma Treatment

The Emory Transplant Center is the only transplant center in Atlanta or the state of Georgia, and one of a few places in the country, performing a novel, life-saving protocol to treat bile duct cancer (cholangiocarcinoma). Cholangiocarcinoma is a lethal and aggressive type of cancer. Traditionally, the disease is treated with resection, surgically removing the tumor, but in many cases the cancer tends to continue to spread around the bile duct. In the past, patients with non-resectable bile duct cancer had little chance of survival.

The new protocol offered at Emory's transplant center combines chemotherapy and radiation with a liver transplant, improving the likelihood of removing the entire source of cancer during surgery. The chemotherapy and radiation treat and sterilize the tumor bed, but using these options alone may eventually cause liver failure and thus the need for replacing the liver by performing a transplant.

Until recent years, patients diagnosed with cholangiocarcinoma had few treatment options and little chance of survival. This new protocol offers hope and optimism to patients with this difficult disease.

Patient Advantages

  • The new protocol combines radiation therapy and chemotherapy with a liver transplant, offering patients with non-resectable bile duct cancer a potentially lifesaving treatment.
  • Utilizing the protocol allows surgeons a greater probability of removing the entire source of bile duct cancer.
  • The 3 year and 5 year survival rate is dramatically increased when using this protocol.

Why Emory?

The Emory Transplant Center is the only program in Georgia performing liver transplant for cholangiocarcinoma. Emory is one of the first centers offering this new protocol in the country as it requires specific surgical training and a multi-modality center; with cancer specialists and a highly trained transplant team.

Emory Liver Transplant Center

Hear My Story

Hear My Story

Read patient testimonials of lives that have been changed by Emory.

Continue reading